About
Basic Data Updated:
1 month agoSpectrum Oncology Private Limited, a biopharmaceutical company, is dedicated to developing innovative drug products that improve the lives of patients. Founded as a wholly-owned subsidiary of Spectrum Pharmaceuticals Inc., the company was established with the goal of advancing the field of medicine through cutting-edge research and development. Incorporated with a clear vision in mind, Spectrum Oncology Private Limited is committed to making a positive impact in the healthcare industry. As manufacturers, dealers, processors, sellers, retailers, buyers, wholesalers, importers, and exporters in the pharmaceutical and fine-chemicals sector, the company strives to provide high-quality products that meet the diverse needs of patients worldwide. With a wide range of offerings, including bulk drugs, intermediates, medicines, allopathic, ayurvedic, homeopathic, and Unani products, Spectrum Oncology Private Limited is dedicated to catering to the ever-evolving needs of the healthcare market. From patent medicines to lotions, cosmetics, formulations, pills, injections, tablets, capsules, and ointments, the company is constantly expanding its portfolio to meet the growing demand for effective and affordable healthcare solutions.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U51397MH2008PTC181835 |
| Company No. | 181835 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 01 May 2008 |
| Date of AGM | 05 Jul 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Mumbai |
Financials of Spectrum Oncology Private Limited
Spectrum Oncology Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.21% increase. The company also saw a substantial fall in profitability, with a 27.6% decrease in profit. The company's net worth Soared by an impressive increase of 23.9%.
Corporate Structure
Unlock access to Spectrum Oncology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Spectrum Oncology Private Limited
Unlock and access historical data on people associated with Spectrum Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spectrum Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Blue Cross Laboratories Private Limited
Active
43 years 10 months Satyanarain Agarwala is a mutual person
Recent activity within the organization
Annual General Meeting
Spectrum Oncology Private Limited last Annual general meeting of members was held on 05 Jul 2023 as per latest MCA records.
05 Jul 2023Balance Sheet
Spectrum Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Purvish Mahendra Parikh was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 14 years 10 months .
30 Jun 2009Director Appointment
Arun Shankar Nanivadekar was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 14 years 10 months .
30 Jun 2009Director Appointment
Satyanarain Rameshwardas Agarwala was appointed as a Director was appointed as a Director on 01 May 2008 & has been associated with this company since 16 years 26 days .
01 May 2008
Recent News, Updates & Announcement
Aurobindo Pharma completes 300 million acquisition of oncology products from USbased pharma giant.Financial Express 02 Mar 2019
- Spectrum Pharmaceuticals Announces the Completion of the Sale of its Marketed Portfolio.
Business Wire 01 Mar 2019
- Indias Aurobindo to buy drug oncology products in 2953 mln deal.
Investsize 18 Jan 2019
Frequently asked questions
What is the Incorporation or founding date of Spectrum Oncology Private Limited?
